Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: cheech who wrote (825)	11/21/1997 2:35:00 PM
From: BigKNY3	Read Replies (2) \| Respond to of 7041

Asensio has responded to my email that complained about their Vasomax press release and their lack of disclosure that they had a short position. Hear it is: BigKNY3 ____________________________________ Subject: Response to Asensio Date: Fri, Nov 21, 1997 10:45 EST From: BigKNY3 Message-id: Subj: Re: Zonagen Date: 97-11-21 09:23:16 EST From: Asensio To: BigKNY3 we did. read it again. good luck. don't invest in over valued stock. specially those that are frauds. good luck. mpa ___________________________________________ My response back to Asensio: _____________________________________________ To: Asensio You never stated that you had a short position in Zonagen in your report. You never mentioned the Schering agreement. By the way, I do not hold a position in Zonagen. In fact, I have a position in Pfizer. But, I resent companies like yours ...that attempt to manipulate stock prices. There may be "some" truth in your report. However, the timing and lack of disclosure in your report have destroyed your credibility and reputation. Sincerely, BigKNY3@aol.com